Schedule 13G ownership disclosure

AMAG PHARMACEUTICALS INC.

Security class unavailable · CUSIP: 00163U106

Event date: 2015-01-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,706,592
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-15-001423
Form type
SC 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Feb 26, 2015
Reporting period
Jan 07, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub